1. Home
  2. VALN vs PNTG Comparison

VALN vs PNTG Comparison

Compare VALN & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • PNTG
  • Stock Information
  • Founded
  • VALN 2012
  • PNTG 2019
  • Country
  • VALN France
  • PNTG United States
  • Employees
  • VALN N/A
  • PNTG N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • PNTG Medical/Nursing Services
  • Sector
  • VALN Health Care
  • PNTG Health Care
  • Exchange
  • VALN Nasdaq
  • PNTG Nasdaq
  • Market Cap
  • VALN 820.0M
  • PNTG 841.6M
  • IPO Year
  • VALN 2021
  • PNTG N/A
  • Fundamental
  • Price
  • VALN $9.43
  • PNTG $28.16
  • Analyst Decision
  • VALN Strong Buy
  • PNTG Buy
  • Analyst Count
  • VALN 4
  • PNTG 6
  • Target Price
  • VALN $15.75
  • PNTG $34.33
  • AVG Volume (30 Days)
  • VALN 21.9K
  • PNTG 299.6K
  • Earning Date
  • VALN 11-20-2025
  • PNTG 11-05-2025
  • Dividend Yield
  • VALN N/A
  • PNTG N/A
  • EPS Growth
  • VALN N/A
  • PNTG 10.47
  • EPS
  • VALN N/A
  • PNTG 0.75
  • Revenue
  • VALN $211,089,992.00
  • PNTG $847,274,000.00
  • Revenue This Year
  • VALN $6.86
  • PNTG $31.78
  • Revenue Next Year
  • VALN $11.85
  • PNTG $18.97
  • P/E Ratio
  • VALN N/A
  • PNTG $37.36
  • Revenue Growth
  • VALN 13.48
  • PNTG 29.89
  • 52 Week Low
  • VALN $3.62
  • PNTG $21.18
  • 52 Week High
  • VALN $12.25
  • PNTG $32.00
  • Technical
  • Relative Strength Index (RSI)
  • VALN 56.66
  • PNTG 69.16
  • Support Level
  • VALN $8.53
  • PNTG $25.57
  • Resistance Level
  • VALN $8.92
  • PNTG $26.68
  • Average True Range (ATR)
  • VALN 0.33
  • PNTG 1.05
  • MACD
  • VALN 0.07
  • PNTG 0.30
  • Stochastic Oscillator
  • VALN 89.57
  • PNTG 98.08

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Share on Social Networks: